ESR1 and neoplasm: While estrogen had no impact on the tumor response in mice, alone or in combination with radiation (Fig. 1), we expanded our analysis to assess if the SERMs raloxifene or tamoxifen would be a useful approach to continue to take advantage of the HPV+-specific overexpression of ERα.